Exchange: NASDAQ·Updated 06:52 AM EDT
News
all
press releases
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
Aspire Biopharma (NASDAQ: ASBP) completes $30M cash acquisition of Dura Driver Control Systems, adding $200M+ in annual revenue.read more...
Benzinga
More News
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier?
The company announced the acquisition of Dura Driver Control Systems for $30 million in cash.
Stocktwits
Healthcare Disruption, AI Biologics, and Wall Street Upgrades Ignite a Midday Market Surge
Healthcare innovators are pushing the markets today. $TGNT, $AGL, $ATRA, $ASBP
24-7 Market News
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity
Aspire Biopharma’s board approved a share repurchase program of up to $5 million, which will be funded from existing cash.
Stocktwits
ASBP Bulls Back In Control After 78% Crash: What Changed?
The company closed a $21 million private placement that lifted its shareholders’ equity above Nasdaq’s minimum listing requirement.
Stocktwits
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff?
The declines came amid leadership uncertainty, financing concerns, and downward revisions in price targets from Wall Street analysts.
Stocktwits
LCID, ABT, ASBP Stocks Hit 52-Week Lows Today: What’s Driving The Selloff?
LCID and ABT each fell about 6% on Thursday, while ASBP plunged 45%, bucking a broader market rally.
Stocktwits
ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin –  Retail Expects Licensing Negotiations Soon
The FDA’s feedback supports a planned new drug application submission in the second half of 2026.
Stocktwits

Advertisement|Remove ads.